Google Map of the Patient Proteome
Terrain is a precision medicine intelligence company focused on making a comprehensive spatial proteomics panel practical for drug development and diagnostics in oncology. We work with big and small technology partners to combine high‑plex tissue imaging, clinical data, and AI to map protein activity in tumors at unprecedented depth.
DNA is the blueprint for a house; proteins are the materials, wiring, and systems that show how the house actually runs and fails. Spatial proteomics measures not just which proteins are present, but where they are in the tissue and how they interact, giving a more direct view of how tumors respond to disease and treatment than genomics alone. Terrain is building an ultra‑plex, high‑sensitivity assay and scalable data pipeline so partners can train AI models, develop therapies, and design diagnostics on top of a far more complete picture of patient biology.
Terrain’s mission is to: (1) develop best‑in‑class spatial proteomics technology with the right partners, (2) deploy high‑throughput clinical LDT testing and generate proprietary patient data, and (3) use that data to power AI‑assisted drug and treatment discovery. Today, we are focused on Horizon 1: delivering a spatial proteomics platform capable of powering the next generation of diagnostics.
